For HIV-1–negative, at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1. See full Indication.


Access the resources below for additional details about APRETUDE, such as the full Prescribing Information, including Instructions for Use, and downloadable resources such as the dosing and administration guide, getting started guide, and more.

Resources for Healthcare Professionals


Prescribing Information


See the full Prescribing Information, including Boxed Warning, for APRETUDE

Read more »

Readiness Consideration Checklist

Review clinical considerations for appropriate patients when prescribing APRETUDE and readying your practice


Getting Started Overview

Get detailed information on getting started with prescribed APRETUDE


Instructions For Use Flashcard

See the Instructions for Use Flashcard for APRETUDE

Read more »

Dosing and Administration Guide

Review Dosing and Administration Information for APRETUDE

Read more »

Healthcare Provider Brochure

Download the APRETUDE brochure for Healthcare Providers


APRETUDE Patient Discussion Guide

View the full APRETUDE Patient Discussion Guide Information

Learn More About How to Prepare and

Administer APRETUDE

View APRETUDE Clinical Trials
APRETUDE Savings Program
Speak to a Representative
Frequently Asked Questions
Answers to frequently asked questions about APRETUDE
View FAQs